President and CEO of Neurocrine Biosciences Inc. (NBIX, Financial) Kevin Charles Gorman sells 15,400 shares of NBIX on 02/28/2011 at an average price of $6.83 a share.
Neurocrine Biosciences Inc. has a market cap of $359.9 million; its shares were traded at around $6.56 with and P/S ratio of 10.8. Neurocrine Biosciences Inc. had an annual average earning growth of 2% over the past 10 years.
Hedge Fund Gurus that owns NBIX: Jim Simons of Renaissance Technologies LLC, George Soros of Soros Fund Management LLC, Steven Cohen of SAC Capital Advisors.
For the complete insider trading history of NBIX, click here.
Neurocrine Biosciences Inc. has a market cap of $359.9 million; its shares were traded at around $6.56 with and P/S ratio of 10.8. Neurocrine Biosciences Inc. had an annual average earning growth of 2% over the past 10 years.
Hedge Fund Gurus that owns NBIX: Jim Simons of Renaissance Technologies LLC, George Soros of Soros Fund Management LLC, Steven Cohen of SAC Capital Advisors.
Directors and Officers Recent Trades:
- Sell: Sr. VP & Chief Medical Officer Christopher Flint Obrien sold 12,320 shares of NBIX stock on 02/28/2011 at the average price of 6.83. Christopher Flint Obrien owns at least 94,794 shares after this. The price of the stock has decreased by 3.95% since.
- Sell: Vice President, Research Dimitri E. Grigoriadis sold 12,320 shares of NBIX stock on 02/28/2011 at the average price of 6.82. Dimitri E. Grigoriadis owns at least 75,433 shares after this. The price of the stock has decreased by 3.81% since.
- Sell: Sr Vice President, Development Haig P. Bozigian sold 12,320 shares of NBIX stock on 02/28/2011 at the average price of 6.83. Haig P. Bozigian owns at least 76,954 shares after this. The price of the stock has decreased by 3.95% since.
For the complete insider trading history of NBIX, click here.
